Moringa recalls spotlight pathogen risks across botanical supply chains

Cassandra Stern

Interview

The FDA investigation, which closed April 1, tied recalled moringa supplements to more than 100 illnesses, drawing renewed industry attention to testing, traceability and supplier verification practices.

Moringa outbreaks triggered recalls across multiple brands.

"We have already seen over 20 total FDA recalls so far this year, with nearly a dozen of those specifically involving pathogens like Salmonella and Listeria."

-Asa Waldstein